“…As shown in Figure 5a, b and c, Bcl-2 and Mcl-1 protein expression suffered a significant decrease after CD5 hypercross-linking in B-CLL cells from patient group A (Bcl-2 MFIR 26.9 ± 7.7 control vs 12.5 ± 6.6 in CD5 hypercross-linked, P Ͻ 0.01, Mcl-1 MFIR 27.7 ± 7.4 control vs 11.5 ± 5.4, P Ͻ 0.01), while Bax protein expression was significantly increased (MFIR 14.9 ± 10.3 con- trol vs 29.5 ± 6.5, P Ͻ 0.01). Because a functional inducible nitric oxide synthase displaying anti-apoptotic activity was demonstrated in B-CLL and hairy cell leukemia, [25][26][27] we also examined iNOS expression after CD5 hypercross-linking in eight group A and 11 group B patients, and found a significant decrease of its levels in the B-CLL cells of group A patients (MFIR 10.8 ± 3.4 control vs 5.1 ± 2.0, P Ͻ 0.01), as shown in Figure 5d. Nothing significant happened with the expression of these apoptosis-related proteins in the cells from the 11 group B patients tested.…”